A Phase 1 Study of MORAb-004 in Patients With Solid Tumor
Phase of Trial: Phase I
Latest Information Update: 09 Jan 2019
At a glance
- Drugs Ontuxizumab (Primary)
- Indications Chondrosarcoma; Gastric cancer; Gastrointestinal stromal tumours; Liver cancer; Solid tumours
- Focus Adverse reactions
- Sponsors Eisai Co Ltd
- 09 Jan 2019 Results published in the Investigational New Drugs
- 08 Nov 2016 Status changed from active, no longer recruiting to completed.
- 19 Jan 2016 Planned End Date changed from 1 Jun 2015 to 1 Sep 2016 as reported by ClinicalTrials.gov record.